Michelle Lock is Relief’s Interim Chief Executive Officer and a member of Relief’s Board of Directors. She has nearly 30 years of biopharmaceutical strategic, operational and commercialization experience.

Mr. Galfetti has more than thirty years of management experience in the pharmaceutical sector including in the areas of business development and licensing, operational strategic management, clinical research and pharmaceutical discovery and development. He held management positions in our organization since 1995 and currently serves as the Company’s Chief Business Officer.

Mr. Reiner has over 30 years of R&D experience. He is leading the development of Relief's pharmaceutical technologies and new products. Mr. Reiner holds a Master's degree in Pharmaceutical Chemistry and Technology from the University of Pharmacy in Milan, Italy.

Ms. Keegan has over 20 years of HR life sciences experience and in building and leading companies from the initial startup phase and scaling through commercialization.

Mr. Gallo has over 10 years legal expertise in the pharmaceutical industry, gained in both large international and start-up corporations. At Relief, he oversees legal and compliance matters, including employment law and intellectual property.

Mr. Einhorn has extensive experience from senior leadership roles within clinical and commercial-stage life science companies. He has held CFO positions at several public and private companies for twenty years, preceded by two decades in investment banking and capital markets.